5Bergh P, Kindblom LG, Gunterberg B, et al. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients[[J]. Cancer, 2000, 88(9): 2122-2134.
6Atalar H, Selek H, Yildiz Y, et al. Management of sacrococcygeal chordomas[J]. Int Orthop, 2006, 30(6): 514-518.
7Baratti D, Gronchi A, Pennacchioli E, et al. Chordoma: natural history and results in 28 patients treated at a single institution[J]. Ann Surg Oncul, 2003, 10(3): 291-296.
8Park L, Delaney TF, Liebsch NJ, et at. Sacral chordomas: Impact of high--dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor[J]. Int J Radiat Oncol Biol Phys, 2006, 65(51: 1514--1521.
9Hof H, Welzel T, DebusJ. Effectiveness of cetuximab/gefidnib in the therapy of a sacral chordoma[J]. Onkologie, 2006, 29(12): 572-574.
10Casali PG, Messina A, Stacchiotti S, et al. Imafinib mesylate in chordoma[J]. Cancer, 2004, 101(9): 2086-2097.
